12
36
40
50
56
e E d i t i o n : N o v / D e c 2 0 2 3 - I s s u e 1 1 - Vo l u m e 4
CHIEF EDITOR Rahul Koul
EDITORIAL Sachin Arya Special Correspondent
Vaishnavi Srivastava Reporter
Brijesh Kumar News Desk
Shanu K Art Direction & Cartoon
BUSINESS HEAD Bhaskar Jha
OPERATIONS Arvind Kumar Executive Oprations
Barun Dey Admin Executive
For advertinsing & marketing write to us : advertising @ biovoicenews . com
Disclaimer : Views and opinions expressed in this e- magazine are not necessarily those of BioVoice News and its publisher PetriDish Media Pvt . Ltd . and / or editors . We , at PetriDish Media Pvt . Ltd . do our best to verify the information published , but do not take responsibility for the absolute accuracy of the information contained in this publication . PetriDish Media Pvt . Ltd . does not accept responsibility for any business or any other decisions taken by the readers on the basis of the information provided herein . All rights reserved . No part of this publication should be reproduced by any means without the written permission from the publisher . Published by : PetriDish Media Pvt . Ltd ., B-1 / 6 , LGF , Hauz Khas , New Delhi – 110016 , INDIA
12
36
40
50
56
COVER STORY
Unveiling the Rise of 10 Trailblazing MedTech Startups
The growing clout of medical technology sector is not just a testament to its onus on innovation but also the improved confidence of investors .
EXPERT INSIGHTS
How is Digital C-Arm Revolutionizing Healthcare Diagnostics in India ?
One of the primary benefits of the C-arm is the ability to provide real-time imaging during surgical procedures , writes Navjot Singh , Executive Director , Trivitron Healthcare
STARTUP SPECIAL
Novel medical technologies to address mental health issues
Bengaluru based BramhAnsh Technologies is on the verge of launching several groundbreaking products , each with the potential to significantly enhance lives
INTERVIEW
“ Biopharma industry has seen strategic advancements in terms of technology enhancement ”
Dr Sanjib Banerjee , Chief Operating Officer ( Biopharma division ), Veeda Clinical Research Limited explains the latest industry trends and initiatives being undertaken by his company
INTERVIEW
“ There are inconstancies across biosimilar classes ”
In an exclusive interaction , Thomas Newcomer ,
04
BioVoiceNews | November / December 2023